| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2006-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e61ae802e5e7a41c68307b713027da4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a962831d34e0c3455ac9a5023c3c9cfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af16f995458e244f07bfb7c91c40306f |
| publicationDate |
2007-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20070106029-A |
| titleOfInvention |
Epithelial Growth Factor Receptor Mutation |
| abstract |
The present invention relates to mutations of epidermal growth factor receptor (EGFr), phosphatidylinositol 3'-kinase ("PI3K") and B-Raf. The present invention relates to a method of treating a tumor comprising a mutated EGFr with a human monoclonal antibody against EGFr. The invention also provides methods and kits for identifying the presence of one or more mutant EGFr, mutant PI3K and / or mutant B-Raf in a sample, and disorders associated with the presence of mutant EGFr, mutant PI3K and / or mutant B-Raf. Or to methods and kits for treating a condition. The invention also relates to methods of treating tumors comprising mutant EGFr, mutant PI3K and / or mutant B-Raf. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200087726-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200087723-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200087727-A |
| priorityDate |
2005-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |